Journal

The recognized brand name medication approved by the FDA, Zepbound™, Mounjaro®, Wegovy® & Ozempic®, is manufactured by Eli Lilly and Company™. We do NOT manufacture this medication and have no direct affiliation with Eli Lilly and Company™

The products offered by Willow are compounded medications prepared by licensed compounding pharmacies. These medications are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to assess their safety, efficacy, or therapeutic equivalence to any FDA-approved products. They are not intended to diagnose, treat, cure, or prevent any disease and are not substitutes for FDA-approved medications such as MOUNJARO® or ZEPBOUND®. Claims regarding effectiveness, safety, or weight loss benefits are not supported by FDA-reviewed studies and pertain only to general mechanisms of tirzepatide, not Willow’s specific formulations. These products are also not approved for cosmetic weight loss and should only be used under the guidance of a licensed healthcare professional. By purchasing or using these products, you acknowledge and accept these terms.